Mesh products first came on the market in the 1950s for use in hernia repairs. In the 1970s, surgeons began using the mesh "off label" for abdominal procedures, and for vaginal procedures in the mid-1990s. The alarming safety controversy regarding pelvic mesh products utilized during the surgical repair of certain female conditions continues to mount.
The mesh products at the center of the litigation are made of a non-absorbable synthetic polypropylene and are implanted transvaginally to treat pelvic organ prolapse or urinary problems.
Studies indicate that nearly 10% of women who have the mesh placed transvaginally experience mesh erosion (also called exposure, extrusion, or protrusion) with 12 months of surgery. Mesh erosion can require multiple surgeries to repair and can be debilitating and life-altering for some women. The other most frequent complications include pain, dyspareunia, infection, urinary problems, bleeding, organ perforation, recurrent prolapse, neuromuscular problems, and vaginal scarring/shrinkage.
There are numerous manufacturers of synthetic vaginal mesh products, and the adverse reports have been linked to multiple manufacturers/brands of the mesh. If you or a loved one have suffered a serious complication following mesh-repair surgery for pelvic organ prolapse or stress urinary incontinence, please contact our trial attorney, Paul Cavonis at (727) 397-5571.